Cosmo Pharmaceuticals Statistics
Total Valuation
CMOPF has a market cap or net worth of 2.38 billion. The enterprise value is 2.24 billion.
| Market Cap | 2.38B |
| Enterprise Value | 2.24B |
Important Dates
The next estimated earnings date is Monday, March 9, 2026.
| Earnings Date | Mar 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 15.94M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.65% |
| Shares Change (QoQ) | -4.28% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 22.41% |
| Float | 8.44M |
Valuation Ratios
The trailing PE ratio is 33.85 and the forward PE ratio is 430.98.
| PE Ratio | 33.85 |
| Forward PE | 430.98 |
| PS Ratio | 11.14 |
| PB Ratio | 4.35 |
| P/TBV Ratio | 18.96 |
| P/FCF Ratio | 29.97 |
| P/OCF Ratio | 27.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.82, with an EV/FCF ratio of 28.18.
| EV / Earnings | 31.83 |
| EV / Sales | 10.16 |
| EV / EBITDA | 22.82 |
| EV / EBIT | 26.95 |
| EV / FCF | 28.18 |
Financial Position
The company has a current ratio of 3.84, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.84 |
| Quick Ratio | 3.59 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.04 |
| Interest Coverage | 763.58 |
Financial Efficiency
Return on equity (ROE) is 12.34% and return on invested capital (ROIC) is 16.65%.
| Return on Equity (ROE) | 12.34% |
| Return on Assets (ROA) | 6.88% |
| Return on Invested Capital (ROIC) | 16.65% |
| Return on Capital Employed (ROCE) | 12.24% |
| Weighted Average Cost of Capital (WACC) | 12.28% |
| Revenue Per Employee | 644,755 |
| Profits Per Employee | 212,209 |
| Employee Count | 332 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 3.64 |
Taxes
In the past 12 months, CMOPF has paid 14.29 million in taxes.
| Income Tax | 14.29M |
| Effective Tax Rate | 16.87% |
Stock Price Statistics
The stock price has increased by +108.28% in the last 52 weeks. The beta is 1.46, so CMOPF's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | +108.28% |
| 50-Day Moving Average | 134.94 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 54.48 |
| Average Volume (20 Days) | 453 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CMOPF had revenue of 214.06 million and earned 70.45 million in profits. Earnings per share was 4.31.
| Revenue | 214.06M |
| Gross Profit | 157.95M |
| Operating Income | 80.71M |
| Pretax Income | 84.74M |
| Net Income | 70.45M |
| EBITDA | 94.49M |
| EBIT | 80.71M |
| Earnings Per Share (EPS) | 4.31 |
Balance Sheet
The company has 148.71 million in cash and 3.17 million in debt, with a net cash position of 145.54 million.
| Cash & Cash Equivalents | 148.71M |
| Total Debt | 3.17M |
| Net Cash | 145.54M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 548.42M |
| Book Value Per Share | 33.91 |
| Working Capital | 162.66M |
Cash Flow
In the last 12 months, operating cash flow was 86.32 million and capital expenditures -6.75 million, giving a free cash flow of 79.57 million.
| Operating Cash Flow | 86.32M |
| Capital Expenditures | -6.75M |
| Free Cash Flow | 79.57M |
| FCF Per Share | n/a |
Margins
Gross margin is 73.79%, with operating and profit margins of 37.70% and 32.91%.
| Gross Margin | 73.79% |
| Operating Margin | 37.70% |
| Pretax Margin | 39.59% |
| Profit Margin | 32.91% |
| EBITDA Margin | 44.14% |
| EBIT Margin | 37.70% |
| FCF Margin | 37.17% |
Dividends & Yields
CMOPF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 94.36% |
| Buyback Yield | -1.65% |
| Shareholder Yield | -1.65% |
| Earnings Yield | 2.95% |
| FCF Yield | 3.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CMOPF has an Altman Z-Score of 6.36 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.36 |
| Piotroski F-Score | 4 |